Whether post-transcriptional regulation of gene expression controls differentiation of stem cells for tissue renewal remains unknown. Quiescent stem cells exhibit a low level of protein synthesis 1 , which is key to maintaining the pool of fully functional stem cells, not only in the brain but also in the bone marrow and hair follicles [2] [3] [4] [5] [6] . Neurons also maintain a subset of messenger RNAs in a translationally silent state, which react 'on demand' to intracellular and extracellular signals. This uncoupling of general availability of mRNA from translation into protein facilitates immediate responses to environmental changes and avoids excess production of proteins, which is the most energy-consuming process within the cell. However, when post-transcriptional regulation is acquired and how protein synthesis changes along the different steps of maturation are not known. Here we show that protein synthesis undergoes highly dynamic changes when stem cells differentiate to neurons in vivo. Examination of individual transcripts using RiboTag mouse models reveals that whereas stem cells translate abundant transcripts with little discrimination, translation becomes increasingly regulated with the onset of differentiation. The generation of neurogenic progeny involves translational repression of a subset of mRNAs, including mRNAs that encode the stem cell identity factors SOX2 and PAX6, and components of the translation machinery, which are enriched in a pyrimidine-rich motif. The decrease of mTORC1 activity as stem cells exit the cell cycle selectively blocks translation of these transcripts. Our results reveal a control mechanism by which the cell cycle is coupled to posttranscriptional repression of key stem cell identity factors, thereby promoting exit from stemness.
. We confirmed that global protein synthesis is very low in qNSCs and markedly increased in aNSCs 1 (Fig. 1c ). In addition, we identified a further increase in neurogenic progenitors and a substantial drop in ENBs derived from neural stem cells (NSCs) (Fig. 1c) , as confirmed by lineage tracing (Extended Data Fig. 1a-h ). Active protein synthesis increases again in LNBs and subsequently decreases gradually in the transition from early to mature neurons (Fig. 1f) . Thus, protein synthesis is dynamically regulated, exhibiting higher levels as stem cells prepare for differentiation and as LNBs prepare for integration.
To investigate how transcript-specific translation relates to transcript abundance, we developed a method to quantify the transcriptome (total mRNA) and translatome (ribosome-bound mRNA) of NSCs and their progeny in parallel in situ. We used the RiboTag mouse line, which enables expression of haemagglutinin (HA)-tagged ribosomal protein RPL22 (RPL22-HA) 11 . We bred RiboTag mice with Cre-inducible fluorescent reporter mouse lines to produce TiCRY mice, which enable parallel ribosome tagging and isolation of the NSCs by FACS, and DiCRY mice, which enable ribosome tagging and FACS isolation of the neurogenic progeny of NSCs, including ENBs, LNBs and neurons (Fig. 2a) . In contrast to previous studies that have used the RiboTag system to examine terminally differentiated cells [11] [12] [13] , targeting cells along their maturation stages requires both sufficient incorporation of the tagged RPL22 in functional ribosomes and no contamination of the target maturation stage by other stages. Therefore, we first confirmed that HA-tagged RPL22 was efficiently incorporated into translating ribosomes without changing global protein synthesis levels (Extended Data Fig. 2a-f ). Next, we validated targeting of each maturation stage by immunohistochemistry for HA, eYFP and different cellular markers ( Fig. 2b-d, Extended Data Fig. 3 ). This strategy enables simultaneous ribosome tagging and fluorescent labelling of four distinct maturation stages that encompass the complete progression of the adult olfactory bulb lineage in vivo.
To examine the transcriptome and translatome, we extracted different RNA fractions from these in vivo maturation stages. mRNAs bound to ribosomes (translatome) could be isolated by immunoprecipitation of RPL22-HA (ribo-IP + ). To correct for nonspecific binding of mRNAs during immunoprecipitation and potential tamoxifen-related effects, we included mock samples of SVZ or olfactory bulb tissue (ribo-IP − ) from mice that do not express the HA tag but would be equally exposed to tamoxifen (Cre − mice). This was compared with total mRNA (transcriptome) of the same target population, isolated from sorted eYFP + cells (Extended Data Fig. 4b ). First, we validated enrichment of the expected population-specific marker genes in the ribo-IP + and RNA fraction by quantitative reverse transcription followed by PCR (qRT-PCR) (Extended Data Fig. 4a, c) . Results of RNA sequencing analysis (RNA-seq) confirmed high enrichment for cell-type specific transcripts at the level of transcriptome and translatome (Extended Data Fig. 5a , b, Supplementary Table 1) . Whereas transcripts associated with NSCs were mostly restricted to NSCs in the SVZ, we found low levels of expression of genes associated with neuroblasts in the NSC population (Extended Data Fig. 5a ). Similarly, transcripts associated with mature neurons were also found at the immature LNB stage. Thereafter, differential expression analysis for stage transitions was performed solely on the basis of transcriptome and translatome data (Extended Data
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Figs. 4d, e, 5c-e, Supplementary Tables 2, 3 ). This analysis revealed that core regulators of neural development were simultaneously represented in the transcriptome and translatome throughout the various differentiation stages (Extended Data Fig. 5c-e) . Collectively, these results demonstrate that this system can be used to obtain populations of high purity, and for integrated stage-specific analysis of transcriptomes and translatomes.
This analysis also revealed the existence of subsets of genes that are differentially loaded onto ribosomes relative to mRNA availability (Extended Data Fig. 4d , e). Furthermore, there was surprisingly little overlap between translatome and transcriptome in the transition from ENB to LNB (Extended Data Fig. 4d , e), but not within each stage (Extended Data Fig. 5f ). Comparison of cells extracted from two different regions, ENB from SVZ and LNB from olfactory bulb, highlighted the presence of different tissue-related nonspecific antibody binders and the need for normalization. We therefore fit a linear model to explain the translatome data by the transcriptome data (representing default translation) and the ribo-IP − controls (representing background binding) for each stage of interest (Extended Data Fig. 6a , Supplementary Information). This showed that abundant transcripts readily bind to ribosomes in NSCs ( Table 4 ), indicating that these cells exhibit low levels of post-transcriptional regulation, as previously reported for homeostatic haematopoietic stem cells 14 . The onset of differentiation was accompanied by increased divergence of transcriptome and translatome ( Fig. 3a-c, Extended Data Fig. 6b , c, Supplementary Table 4), with neurons showing the highest degree of uncoupling between transcriptome and translatome. The analysis of explained variance also confirmed that translation efficiency accounts for a substantially larger fraction of the translatome data than RNA abundance in neurons (Extended Data Fig. 6d, e) . We further examined the subset of transcripts sharing common translational control at the different maturation stages (Fig. 3b, c) . First, we observed many transcripts that were repressed or enhanced exclusively at the ENB stage, further validating some of them by qRT-PCR and western blot (Extended Data Fig. 6f, g ). The translation efficiency predicted by the linear model correlated strongly with changes in protein level for validated candidates (Extended Data Fig. 6g ). Second, LNBs and neurons had the highest share of repressed transcripts, indicating that post-transcriptional repression of translation begins at the LNB stage and is maintained in neurons. Collectively, these data indicate that cells become increasingly dependent on post-transcriptional control as they differentiate to mature neurons.
We next focused on the exit from the stem cell state in the transition to migrating ENBs. This is the first stage at which there is substantial regulation of ribosome binding of mRNAs. The subset of repressed transcripts consists of multiple ribosomal genes as well as the prominent developmental transcription factors PAX6 and SOX2 (Fig. 3b-d) , which-together with SOX9 15 -are critical for determining stem cell identity of embryonic and adult radial-glial progenitors. We next validated the profile of SOX2 in tissue and freshly isolated cells (Fig. 3e-g , Extended Data Fig. 7 ). ENBs exhibited a profoundly reduced efficiency of Sox2 translation as compared to NSCs in the brain. Together, these data demonstrate a gradual repression of Sox2 translation in the transition from NSCs through neurogenic progenitors to ENBs. Notably, Sox2 mRNA subsequently reassociates with ribosomes in LNBs and neurons. Indeed, we further validated that newly generated calretinin-positive periglomerular neurons, but not newborn neurons in the granular cell layer, exhibit high levels of SOX2 protein (Extended Data Fig. 7f, g ). Thus, translation of Sox2 transcripts is transiently repressed in ENBs and becomes re-expressed in a subset of newly differentiated olfactory bulb neurons.
Next, we investigated whether the set of 282 translationally repressed transcripts in ENBs shared distinct features when compared to non-repressed transcripts. De novo motif analysis of repressed transcripts identified a stretch of pyrimidines (TCTTTC or CTCTTT, Supplementary Table 5 ) that was enriched in the 5′-untranslated region (5′-UTR); we call this the pyrimidine-rich motif (PRM). This motif resembles the 5′-terminal oligopyrimidine (TOP) motif, which is particularly sensitive to mTORC1 activity 16 . Unlike canonical TOP motifs, but similar to the pyrimidine-rich translational element 17 , the PRM is not always located at the terminal end of the 5′-UTR. Similar to TOP, PRM was found in transcripts that encode components of the translation machinery (Fig. 4a, Extended Data Fig. 8a) . Notably, PRMcontaining transcripts were not repressed at the LNB stage, despite the larger number of translationally repressed transcripts at this stage (Extended Data Fig. 8b ). Thus, we hypothesized that contrary to previous reports 18 , mTORC1 activity might be low in ENBs and high in NSCs and LNBs. Phosphorylation of the 40S ribosomal protein S6 (rpS6)-an indicator of mTORC1 activity-was low in ENBs, whereas NSCs showed heterogeneous levels, probably reflecting their different activation state (Extended Data Fig. 8c, d ). We further assessed expression of mTOR-related factors in freshly isolated NSCs and ENBs by western blotting. As predicted by our linear model (see Supplementary Information), ENBs exhibited a downregulation of phosphorylated rpS6 (pS6) and phosphorylated p70 S6 kinase (p70 S6K), and of total TSC2 and RHEB in comparison to NSCs (Extended Data Fig. 8d ). By contrast, LNBs in the olfactory bulb showed substantially higher levels of pS6 than neighbouring neurons (Extended Data Fig. 8e) . Thus, the specific repression of PRM-containing transcripts in ENBs but not in LNBs could be caused by a decrease of mTORC1 activity. We tested whether counteracting the drop in mTORC1 activity would impair transition of NSCs into neuroblasts, or whether mTOR activation would reprogram ENBs back to stemness and regulate Sox2 translation. We used phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P 3 ) 19 or Torin 16, 20 , respectively, to activate or inhibit mTOR. Increasing mTOR activity in cultured NSCs induced to become ENBs or in freshly isolated , n = 69 cells. Data are mean ± s.d. from n = 2 biological replicates. Two-tailed MannWhitney U-test was applied for each individual comparison *P = 0.0189, ****P < 0.0001. Scale bars, 10 µm.
ENBs enabled translation of Sox2 transcripts (Fig. 4b, d , Extended Data Fig. 8g, h ). The increase in mTOR activity blocked NSC transition to ENBs and reset ENBs to stemness (Fig. 4b, c, Extended Data Fig. 8g) .
Next, we examined the mTORC1-dependent rate of ribosomal load of PRM + and PRM − transcripts. We used NSC cultures to increase the input material to obtain cell fractions with distinct ribosome content by sucrose-gradient fractionation of Torin-or vehicle-treated NSCs. Most PRM + (and TOP + ), but not PRM − transcripts, shifted to lighter fractions upon Torin treatment, indicating that their translation depends on mTORC1 activity (Extended Data Fig. 8f) . A similar shift was not detected for Sox2 transcripts (Extended Data Fig. 8f) ; we hypothesized that this could be a result of differences between in vitro and in vivo conditions. Indeed, acute inhibition of mTOR activity by Torin or the EGFR inhibitor erlotinib (used to mimic the loss of EGFR that occurs during the transition of NSCs to ENBs) led to a partial reduction in pS6, phosphorylated 4E-BP and phosphorylated p70 S6K, but not to reduced expression of the mTORC1 activator RHEB, as found in freshly isolated ENBs in comparison to NSCs (Extended Data Figs. 8d, 9a, c). As mTOR activity is tightly regulated throughout the cell cycle 21 , and around 70% of active NSCs in vivo are in G0 or G1 phase 22 , we synchronized NSCs by double thymidine block. Cells in late G1 phase exhibited downregulation of 4E-BP, p70 S6K and RHEB proteins and an even higher 
loss of phosphorylation of 4E-BP and p70 S6K upon Torin treament, as compared to unsynchronized NSCs (Extended Data Fig. 9b ). Most importantly, repression of ribosomal loading of Sox2 transcript and downregulation of SOX2 protein upon Torin treatment was detected at late G1 phase (Fig. 4e, Extended Data Fig. 9b ). Torin-mediated repression of Rpl18 was present in unsynchronized cells; however, it became more prominent at G1 (Fig. 4e, Extended Data Fig. 8f ). This is consistent with previous reports indicating that TOP-containing ribosomal mRNAs show higher dependence on the level of phosphorylated p70 S6K, whereas RNAs such as those encoding CD44, vimentin, YB1 and SOX2 are more dependent on 4E-BP phosphorylation 17, 23 . Our results show that in G1, but not in unsynchronized cultured NSCs, Torin fully blocks mTOR-dependent effectors, 4E-BP and p70 S6K. Together, these data indicate that late G1 phase enables the profound drop of mTORC1 activity required for post-transcriptional repression of Sox2 in NSCs. Some transcripts, such as Dusp4, show an opposite shift towards heavier fractions upon Torin treatment in G1 phase, indicating that the reduction in mTORC1 activity would facilitate their translation (Fig. 4e, Extended Data Fig. 9d, e) . Next-generation sequencing technologies enabled identification of many mRNAs that are resistant to mTOR repression, and some that are stimulated 16, 17 . The specific features that make mRNAs resistant to mTOR suppression have not been identified; however, the ability of N 6 -methylated adenines localized in the 5′-UTRs to directly attach 40S in an eIF4E-independent manner may be one such feature 24 . Motif analysis revealed enrichment in the coding region of a consensus motif for N 6 -methyladenosine, CGCAAC (as shown in Supplementary Table 5 ). Future studies of N 6 -methylated adenines should further our understanding of how low mTORC1 activity and/or cell-cycle exit increase translation efficiency for this set of transcripts.
Other transcripts exhibiting similarly increased translation in vivo, such as Sp8, are strongly influenced by the cell cycle (Extended Data  Fig. 9d, e) . These genes are overrepresented in the neuron-differentiation Gene Ontology categories (Extended Data Fig. 8a ). Thus, a decrease in mTORC1 activity, together with cell-cycle state, orchestrates 
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Per cent mRNA in fraction + cells) of DCX (red) and SOX2 (green) expression in NSCs after 7 days in vitro culture under differentiating conditions, exposed to PtdIns(3,4,5)P 3 (PIP3), PtdIns(3,4,5)P 3 + Torin or DMSO control. Scale bar, 10 µm. SOX2: *P = 0.048 (PtdIns(3,4,5)P 3 versus DMSO), *P = 0.042 (PtdIns(3,4,5) P 3 versus PtdIns(3,4,5)P 3 + Torin); DCX: ***P = 0.0005 (PtdIns(3,4,5) P 3 versus DMSO), **P = 0.0011 (PtdIns(3,4,5)P 3 versus PtdIns(3,4,5) P 3 + Torin); two-tailed Student's t-test. c, Newly sorted ENBs were exposed to PtdIns(3,4,5)P 3 , PtdIns(3,4,5)P 3 + Torin or DMSO control. Sphere-forming capacity was assessed after seven days in vitro culture conditions. **P = 0.0019 (PtdIns(3,4,5)P 3 versus DMSO), **P = 0.0046 (PtdIns(3,4,5)P 3 versus PtdIns(3,4,5)P 3 + Torin; two-tailed Student's t-test. Scale bar, 20 µm. d, Representative images and quantification of SOX2 (red) and pS6 (turquoise) expression in NSCs and ENBs after treatment with PtdIns(3,4,5)P 3 , PtdIns(3,4,5)P 3 + Torin, or fixed immediately after sorting (control). Scale bar, 5 µm. SOX2: ***P = 0.0005, ***P = 0.0004; pS6: **P = 0.0095, ***P = 0.0009; two-tailed Student's t-test. In b-d, data are mean ± s.d. from n = 2 biologically independent experiments. e, Representative plots showing the distribution of mRNAs of indicated genes across the gradient fractions of the polysome profiles of synchronized NSCs at 2 h following double thymidine block. Note a shift of PRM + mRNAs (Rpl18, Sox2) but not PRM − mRNAs (such as Actb) to the fractions of light polysomes and non-translating complexes following Torin treatment. Dusp4 mRNA showed a mild shift toward the heavy polysome fraction following 2-h Torin treatment. Results are expressed as mean and representative of three biological replicates (see Source Data).
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post-transcriptional repression of stemness and enhancement of neuronal differentiation processes. This is consistent with the finding that long-term activation of mTORC1 via deletion of TSC2 in human embryonic stem cells generated neuron-like cells with increased expression of neural stem cell and proliferation markers including SOX2, and decreased expression of neuronal markers 25 . Ribosomal footprinting of stages along forebrain differentiation of human embryonic stem cells in vitro highlighted the importance of mTORC1-driven expression of translation components 26 . Activation of mTORC1 is also found in injured muscle stem cells transitioning from a quiescent (G0) to a quiescent-primed state (G Alert ) 27 . Together, these results indicate that quiescent stem cells require mTORC1 activity to enter a primed-active state, and subsequent exit from stemness and differentiation demand downregulation of this activity. Dysregulation of this transition is found in ageing and cancer 28 . In addition, our data underline the importance of studying the molecular underpinnings of lineage transitions in vivo and reveal a differential sensitivity of targets to mTORC1 inhibition that is dependent on the cell-cycle state. This might represent a more general mechanism by which mTOR and the cell-cycle state act together to control stemness. These results offer a comprehensive genomic view on translational control during neuron generation in the adult brain (Extended Data Fig. 9f ), adding another layer to our knowledge of the molecular mechanisms controlling stem cell differentiation.
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Mice. Tlx-CreER mice were a gift from H.-K. Liu 29 (Tlx is also known as Nr2e1). These mice were bred with Rosa26-LSL-eYFP or Rosa26-tdTomato mice (Jackson Laboratory) to generate Tlx-eYFP or Tlx-tdTomato offspring. The Tlx-recombined population overlapped with the previously characterized GLAST + PROM + population of NSC, confirming that the TLX-labelling and FACS approach isolate the equivalent subset of cells in each strain (Extended Data Fig. 1a, b) . The Dcx-CreER mice were a gift from M. Schwanninger 30 , similar to the Tlx-CreER mice, the Dcx-CreER mice were bred with Rosa26-LSL-eYFP mice to generate Dcx-eYFP offspring. In the absence of tamoxifen, there were no eYFP-expressing cells in the brain of adult Tlx-eYFP mice (Extended Data Fig. 1c, d ), demonstrating that this line is not leaky. The absence of leakiness of the Dcx-eYFP line, could be confirmed by the fact that labelled ENBs migrate towards the olfactory bulb, and at four weeks after induction with tamoxifen, no labelling was observed in the SVZ (Extended Data Fig. 3h-j) .
These reporter mouse lines were crossed to RiboTag mice (B6N.129-Rpl22tm1.1Psam/J from Jackson Laboratory) to generate TiCRY (Tlx-CreERRpl22.HA-eYFP), NiCRY (Nes-inducible-Cre-Rpl22.HA-eYFP) and DiCRY (Dcx-CreER-Rpl22.HA-eYFP) transgenic mouse lines. Males between 8 and 12 weeks of age were used for all sequencing experiments. Additionally, TiCROMATO mice (Tlx-CreER-Rpl22.HA-Tomato) were used whenever eYFP expression was considered to be too weak. All mice were backcrossed to a C57BL/6 background. The RiboTag mice express HA fused to RPL22, which is one of the most stable ribosomal components 31 , and is localized on the exposed solvent side of 60S and is not involved in either mRNA or tRNA binding or ribosomal dynamics during translation 32 . The HA tag enables isolation of ribosome-associated mRNA (ribo-IP + ). For isolation of the total mRNA fraction, cells were sorted according to eYFP expression.
All subsequent experiments using transgenics were conducted using both male and female mice up to 16 weeks of age. Cre-mediated recombination was induced by oral gavage of tamoxifen (Sigma-Aldrich) at a concentration of 200 mg per kg body weight (in ~100 µl 90% sunflower oil/10% EtOH). Tamoxifen was administered twice per day for a total of 2-3 injections and the experiments were conducted 3-4 days after recombination (4 weeks after recombination to address neurons in the olfactory bulb), as ribosome turnover in the brain takes several days 33 . The conditions varied slightly between mouse lines owing to recombination efficiencies and total number of cells. NSCs express the oestrogen receptor, and inhibition of the receptor by tamoxifen may potentially influence proliferation of adult neural stem cells 34, 35 . Therefore, to control for potential tamoxifen-related changes of gene expression, we used Cre mice exposed to tamoxifen (ribo-IP − ). The absence of Cre recombination without tamoxifen induction was additionally confirmed (Extended Data Fig. 1 c-e) .
C57BL/6 male mice between 8 and 12 weeks of age were used for all other experiments. All mice were bred in-house at the DKFZ Center for Preclinical Research. Animals were housed under standard conditions and fed ad libitum. All procedures were in accordance with the DKFZ guidelines and approved by the Regierungspräsidium Karlsruhe. Cell sorting. Animals were euthanized by cervical dislocation and brains were immediately placed in dissection solution on ice. The lateral SVZ was microdissected as a whole mount as previously described 36 , and the olfactory bulb was dissected out. Tissue from 1-2 mice was used per replicate (SVZ or olfactory bulb) for sequencing experiments. Tissue from up to five mice was pooled per sample for OPP experiments. Tissue was digested with trypsin and DNase using the Neural Tissue Dissociation kit in a Gentle MACS Dissociator (Miltenyi). To study the transcriptome of TiCRY and DiCRY mouse lines, we isolated eYFP + cells by FACS (Extended Data Fig. 4b) Fig. 1a, i ). Cells were sorted using the following antibodies: GLAST (ACSA-1)-PE (Miltenyi, 1:20), CD45-APC-Cy 7 (BD, 1:200), O4-APC or APC-Cy 7 (Miltenyi, 1:50), Prominin-APC or PerCP-eFluor710 (eBioscience, 1:75), Ter119-APC-Cy 7 (Biolegend, 1:100), PSA-NCAM-PE-Vio770 (Miltenyi, 1:50), conjugated EGF-Alexa488 (Life Technologies, 1:100). During cell sorting, Sytox blue (Thermo Fisher Scientific, 1:1,000) was used to exclude dead cells.
For transcriptome analysis, 200-500 cells were sorted directly into Picopure lysis buffer (Thermo Fisher Scientific). Sequencing libraries were prepared as described in the following section for immunoprecipitation samples. RiboTag immunoprecipitation and sequencing. RiboTag immunoprecipitation was conducted essentially following the original protocol 11 with minor modifications. Mice were perfused with Hank's Balanced Salt Solution (HBSS) supplemented with the translation inhibitor cycloheximide (200 µg/ml) for stabilization of RNA-ribosome complexes. Tissue of interest was dissected and placed in tubes containing 1.4-mm ceramic beads (PEQLAB). Homogenization buffer (50 mM Tris HCl, 100 mM KCl, 12 mM MgCl 2 , 1% NP-40, 1 mM DTT, 1× complete protease inhibitor (Roche), 200 U/ml RNAsin (Promega), 100 µg/ml cycloheximide, 1mg/ml heparin) was added to a weight per volume ratio of 3% (for example, 0.015 g in 500 µl) and tissue was homogenized using Minilys Personal Homogenizer (Bertin Instruments). Samples were centrifuged and supernatant was used for immunoprecipitation. Anti-HA antibody (Covance, 1:100) was added for four hours (indirect conjugation) following addition of Protein G magnetic beads (100 µl, prewashed with homogenization buffer, Thermo Fisher Scientific) and overnight incubation (all steps at 4 °C). Supernatant was discarded and beads were washed three times for ten minutes in high-salt buffer (50 mM Tris HCl, 300 mM KCl, 12 mM MgCl 2 , 1% NP-40, 1 mM DTT, 100 µg/ml cycloheximide). Finally, beads were resuspended in Picopure lysis buffer (supplemented with β-mercaptoethanol, 10 µl/ml, Sigma) and RNA was isolated by Picopure RNA isolation kit (Thermo Fisher Scientific) following the manufacturer's protocol. For enrichment analysis, a fraction of the RNA was converted to cDNA using the SuperScript VILO kit (Thermo Fisher Scientific). Sequencing libraries were prepared using Smart-seq2 technology as previously described 37 . Reverse transcription was performed using an oligo (dT) primer and a locked nucleic acid (LNA)-containing template-switching oligonucleotide (Exiqon). Full-length cDNAs were amplified by 15-18 cycles of PCR using KAPA HiFi DNA polymerase (KAPA biosystems). cDNAs were then converted into libraries for Illumina sequencing according to the Nextera XT Sample Preparation (Illumina) protocol. Samples were sequenced in an Illumina HiSeq 2000. Cell culture. For NSC isolation, 8-12-week-old wild-type C57BL/6, TiCRY or NiCRY mice (1 w.p.i.) were killed by cervical dislocation. A whole mount of the SVZ was microdissected 36 and cells were isolated using trypsin (or papain) and DNase using the Neural Tissue Dissociation kit in a Gentle MACS Dissociator (Miltenyi). NSCs were cultured in Neurobasal medium (Thermo Fisher Scientific) supplemented with 20 ng/ml of basic fibroblast growth factor (bFGF) and epidermal growth factor (EGF).
To sort neurons from the olfactory bulb, we dissociated this tissue and isolated cells that were identified as LNBs, early neurons or mature neurons by marker expression after fixation. Freshly isolated cells for OPP administration (translation analysis) or RNA in situ hybridization were plated in poly-d-lysine-and laminincoated Lab-Tek chambers (Thermo) in Neurobasal medium lacking growth factors. OPP was added to the culture (50 µM) 2 h after plating, and after 1 h incubation, cells were fixed for 20 min using 2% paraformaldehyde (PFA) in the medium. For RNA in situ hybridization, cells were fixed for 20 min using 2% PFA in the medium 2 h after plating.
For cell synchronization, freshly isolated NSCs were used at passage 2, and double thymidine block was applied to accumulate them at the G1-S transition. NSCs were incubated in the presence of 2 mM thymidine in normal growth medium for 19 h. Thereafter, cells were washed twice with Neurobasal medium and incubated for 8 h in Neurobasal medium without thymidine to release the block. Thymidine was again added at 2 mM for another 16 h to provide a complete block of NSCs at G1/S. For the following treatment with Torin, NSCs were washed twice with Neurobasal medium and incubated under normal growth condition as indicated. Erlotinib, Torin and PI(3,4,5)P 3 treatment. The membrane-permeant PI(3,4,5)P 3 was used to activate mTORC1 19 , and the mTOR inhibitor Torin was used to fully inhibit it 16, 20 . The EGFR inhibitor erlotinib was used to mimic the loss of EGFR during the transition from NSCs to ENBs.
Primary NSCs were exposed to erlotinib (5 µM, stock in DMSO; Sigma-Aldrich) or Torin (250 nM, stock in DMSO) for the indicated time periods. DMSO was used as a vehicle control. Thereafter, cells were collected in lysis buffer and analysed by western blot.
For the PtdIns(3,4,5)P 3 treatment, NSCs and ENBs were sorted from SVZ and either resuspended in Neurobasal medium with the growth factors or fixed with 2% PFA. Thereafter, ENBs were either treated with PtdIns(3,4,5)P 3 or PtdIns(3,4,5)P 3 + Torin. Torin (250 nM) treatment was performed for 5 min before PtdIns(3,4,5)P 3 stimulation. PtdIns(3,4,5)P 3 /AM(DOG) (1′,2′-Di-O-octanoyl-snglycerol 2,6-di-O-butyryl phosphatidylinositol-3,4,5-trisphosphate heptakis (acetoxymethyl) ester) was synthesized as previously described 38 and prepared as a 50 mM stock solution in DMSO and stored at −80 °C. Just before use, PtdIns(3,4,5) P 3 was mixed with 20% pluronic F-127 in DMSO (Invitrogen) in a 1:0.5 ratio to facilitate cell entry. The PtdIns(3,4,5)P 3 /AM-pluronic-DMSO mixture was resuspended in 50 µl NB medium to a final concentration of 10 µM and immediately added to cells for 10 min. PtdIns(3,4,5)P 3 was then removed and fresh medium and additional Torin were added for a further 2 h. The control sample was treated with DMSO as a vehicle control. Cells were fixed and further processed for immunocytochemistry. Neurosphere assay with freshly isolated ENBs. ENBs, freshly sorted by FACS, were treated with PtdIns(3,4,5)P 3 , Torin or DMSO as described above. Then, 500 cells were plated on poly-d-lysine-and laminin-coated 16-well Lab-Tek chambers (Thermo). The number of spheres was analysed after seven days in culture.
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, as assessed by their de novo-acquired ability to form neurospheres in comparison to the non-sphere forming capacity of ENBs treated with vehicle or PI(3,4,5)P 3 + Torin (Fig. 4c) . Differentiation assay of NSCs after treatment with Torin and PI(3,4,5)P 3 . NSCs (at passage 6) were plated at a density of 6 × 10 4 cells on poly-d-lysine-and laminin-coated 16-well Lab-Tek chambers (Thermo) with Neurobasal medium including growth factors (EGF and bFGF). Following overnight culture, growth factors were withdrawn and 4 h later NSCs were treated with PtdIns(3,4,5)P 3 , Torin or DMSO as described above. After seven days under differentiation conditions, cells were fixed with 2% PFA and immunofluorescence staining for SOX2 and DCX was performed as described below. Upon growth factor withdrawal, NSCs readily generated neuroblasts, as assessed by their higher DCX and lower SOX2 protein expression (Fig. 4b) . Western blot analysis and qRT-PCR. A pool of 10-15 mice was used to freshly sort around 10 4 NSCs and ENB cells. These were collected in PBS with 10% FBS on ice for protein analysis by western blot. For re-probing, membrane stripping was performed according to the protocol from Cell Signaling technologies. For primary cultures, cells were collected, washed with PBS and lysed as described before.
The following primary antibodies were used for western blot analyses. Phosphorylated EGFR-Tyr1068 (rabbit, 1:1,000), EGFR (rabbit, 1:1,000), pS6-Ser240/244 (rabbit, 1:1,000), rpS6 (rabbit, 1:10,000), phosphorylated p70 S6K-Thr421/Ser424 (rabbit, 1:1,000), p70 S6K (rabbit, 1:1,000) and tuberin/TSC2 (rabbit, 1:1,000) were from Cell Signaling Technologies; DUSP4 (rabbit, 1:800), RHEB (mouse, 1:1,000), RPS20 (rabbit, 1:1,000), SOX2 (rabbit, 1:1,000), VASH2 (rabbit, 1:1,000), vinculin (rabbit, 1:5,000) were from Abcam; actin (rabbit, 1:1,000) was from Santa Cruz; SP8 (rabbit, 1:1,000) was from Millipore; PLP1 (chicken, 1:400) was from Neuromics; anti-HA (mouse, 1:1,000) was from BioLegend and RPL22 (custom-made, mouse, 1:500) was a gift from D. Wiest.
For qRT-PCR analysis of mRNA abundance in freshly sorted NSCs and ENBs, we collected around 5,000 cells of each type. For primary NSCs in culture, around 10 5 cells were used. Total RNA was extracted with the Picopure RNA isolation kit (Thermo Fisher Scientific). cDNA was synthesized using the SuperScript VILO kit (Thermo Fisher Scientific). PCR reactions were performed in three technical replicates with the Power SYBR Green PCR Master Mix (Thermo Fisher Scientific) and QuantiTech primers specific for mouse genes (Qiagen). Cycles of amplification were made in the CFX384 Real-Time System (Bio-Rad). Excel (Microsoft) was used to analyse the PCR data. RNA in situ hybridization, immunocytochemistry and immunohistochemistry. RNA in situ hybridization. RNA in situ hybridization was performed using RNASCOPE Multiplex Fluorescent Assay (Advanced Cell Diagnostics) with one major modification of the protocol: to allow subsequent protein staining, we skipped pre-treatment steps as described in the manufacturer's protocol and instead only performed extended (15 min, 95 °C) heat-based target retrieval using a modified citrate buffer (Target Retrieval Solution, Dako). Additional immunofluorescence was done following the mRNA detection according to standard procedures. In situ hybridization was used to validate Sox2 mRNA, and immunohistochemistry was used to quantify SOX2 and DCX protein levels in Tlx-eYFP reporter mice, and to assess Sox2 mRNA and SOX2 protein in NSCs and ENBs in parallel. DiCRY mice were used to analyse SOX2 translation in newborn neurons. Sox2 mRNA (molecules/cell) and protein (total fluorescence) expression was quantified by manual segmentation. Immunocytochemistry. To visualize mTORC1 activity we followed phosphorylation of rpS6 specifically in NSCs and ENBs in situ. Freshly isolated or cultured cells were fixed for 20 min at room temperature using medium containing 2% PFA. Staining was performed using standard procedures with following antibodies: anti-SOX2 (mouse, Abcam, 1:500 or rabbit, Abcam) and pS6(Ser240/244) (rabbit, Cell Signaling, 1:1,000). The quantification of the expression intensities for SOX2 and pS6 was performed with ImageJ/Fiji software. For each condition, 20 cells were analysed and the intensity was normalized to the cell area. OPP visualization was done after all staining steps. For this, the alkyne group of OPP was detected using an Alexa Fluor 488-or Alexa Fluor 647-coupled azide with the Click-iT Cell Reaction Buffer Kit (Life Technologies). Immunohistochemistry. For tissue staining, mice were transcardially perfused, first with HBSS and then with 4% PFA, following overnight post-fixation. Vibratome sections of 50-70 µm were prepared for tissue staining only; for RNA in situ hybridization, cryosections of 11-13 µm were prepared. The following antibodies were used for immunocytochemistry and immunohistochemistry: anti-DCX (goat, Santa Cruz, 1:500), anti-DCX (guinea-pig, Merck Millipore, 1:1,000), antipS6(Ser240/244) (rabbit, Cell Signaling, 1:1,000), anti-NeuN (mouse, Merck Millipore, 1:500), anti-pH3 (mouse, Merck Millipore, 1:500), anti-GFAP (mouse, Merck Millipore, 1:1,000), anti-GFAP (rabbit, Merck Millipore, 1:1,000), anti-HA (mouse, Covance, 1:1,000), anti-GFP (chicken, Aves, 1:1,000), anti-RFP (rabbit, Rockland, 1:1,000), anti-SOX2 (goat, Santa Cruz, 1:500), anti-SOX2 (rabbit, Abcam, 1:1,000), anti-calretinin (rabbit, Merck Millipore, 1:1,000), anti-GLAST (guinea pig, Frontier, 1:1,000), anti-MASH1 (rat, RDI Fitzgerald, 1:500). Polysome fractionation and protein and RNA isolation. Polysome fractionation for cultured cells with subsequent protein and/or RNA isolation was performed essentially following a previously published protocol for CNS tissue, leaving out initial steps of tissue preparation 39 . Cells were acutely treated for 5 min with cycloheximide in culture medium (100 µg/ml) and subsequently collected, washed in PBS with cycloheximide and lysed in polysome lysis buffer (PLB, 20 mM Tris HCl, pH 7.4, 5 mM MgCl 2 , 120 mM KCl, 1% NP40, 100 µg/ml cycloheximide, 1× complete protease inhibitor (Roche), 200 U/ml RNAsin (Promega), 14 mM β-mercaptoethanol). Lysates were centrifuged and the supernatant was added on sucrose gradients (17.5-50%). Samples were centrifuged for 2.5 h at 35,000 rpm at 4 °C in an ultracentrifuge (Beckman L8M). Samples were fractionated in 12 fractions, each containing a 1-ml sample, using an Isco fractionator while monitoring absorption at 254 nm. RNA isolation was performed using acidic phenolchloroform-isoamylalcohol (PCI, 25:24:1, Thermo Fisher Scientific). Alternatively, proteins were precipitated using trichloroacetic acid. Imaging. Confocal images were acquired using a Leica TCS SP5 confocal microscope. ImageJ was used for processing and images were only adjusted for brightness and contrast. For OPP quantifications, all images within compared groups were acquired with identical settings. Analysis was performed in ImageJ/Fiji software using a custom-written macro for unbiased segmentation and quantification of pixel intensity and cell size. OPP quantifications are depicted as the integrated pixel intensity within a cell and normalized to a reference group within the same experiment. In graphs, mean and s.d. are shown. Illustrator CS5 (Adobe) was used to create figures. Processing and analysis of total mRNA and ribo-IP sequencing data. Sequence reads from both total mRNA and ribo-IP samples were aligned to the mouse reference genome (ENSEMBL Release 80) and the ENSEMBL gene annotation (Release 80) using the STAR alignment algorithm v020201 40 with the proposed the ENCODE settings to generate gene-specific raw count values. Expected gene counts and TPM values (transcripts per million) were computed using RSEM v1.2.21 41 with bowtie2 v2.2.6 with the same genome and version and annotation. Differential gene expression analysis between developmental stages of the total mRNA sequence data was conducted using the R/Bioconductor package DESeq2
42
. P values were computed by fitting a negative binomial distribution and subsequent testing by a Wald test, and corrected for multiple testing by controlling the FDR applying the method of Benjamini-Hochberg. For ribo-IP + sequencing data, the same analysis was applied to analyse the differential abundance of ribosome-bound RNA.
To assess the translation efficiency, genes with an average log 2 read count of at least 10 were considered. First, a linear model was fitted for each replicate individually to explain the ribo-IP + sequencing data by a linear combination of total mRNA sequence data (representing efficient translation) and ribo-IP − (representing tissue background expression). Analysis of variance of this part provides the proportion of variance that is explained by total mRNA and by ribo-IP − in each replicate separately. The ribo-IP + sequencing signal that cannot be explained by total mRNA or ribo-IP − can be explained by either enhanced or repressed translation. Transcripts that were less abundant in ribo-IP + sequencing compared to total mRNA (and ribo-IP − ) than expected were designated as 'repressed' , suggesting that active mechanisms prevent them from ribosome association. By contrast, transcripts with higher ribosome association than expected based on total mRNA and ribo-IP − data were designated as 'enhanced' , indicating that their ribosome association is actively promoted. To assess whether the detected enhanced or repressed translation was statistically significant, we compared the two replicates and tested whether the remaining signal was different from zero by applying a moderated t-test implemented in the R/Bioconductor package limma 43 . P values were corrected for multiple testing by the method of Benjamini-Hochberg. At this stage the analysis of variance provides the proportion of variance that can be explained by translation efficiency (correlated signal) and the remaining unexplained variance (uncorrelated signal) that is most likely to be of technical source. Full documentation of the computational analysis can be found in the Supplementary Information. De novo motif analysis. 3′-UTR, 5′-UTR and protein-coding sequences of all protein-coding genes were tiled in 6-mer nucleotide sequences. For each developmental stage separately, for translationally repressed and enhanced genes separately, and for 3′-UTR, 5′-UTR and coding sequence separately, an unbiased motif analysis was performed. For each possible 6-mer, the number of genes containing the tested 6-mer in the set of repressed (enhanced) genes and in the remaining genes was computed. A P value was computed by a binomial test and corrected by the method of Benjamini-Hochberg. All over-or under-represented motifs at a FDR of 10% were reported (Supplementary Table 5 ).
Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper.
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Code availability. Complete documented software is available in the Supplementary Information. The complete R/Bioconductor code used for the analysis is available at https://github.com/Martin-Villalba-lab/Data/tree/master/ Nature_2019. . Results are presented from two biological replicates (n = 2); data are mean ± s.d. c, Scheme of the experimental design. Tlx-CreER mice were crossed with Rosa26-LSLeYFP mice to generate Tlx-iYFP mice. Three groups of mice were treated with the indicated tamoxifen regimens by intraperitoneal injection and euthanized after two days. Each arrow represents 2 daily injections with a 12-h interval. neurons or NeuN − neurons in different layers of the olfactory bulb (n = 3 mice). Scale bar, 100 µm. d-g, Estimating cell-type composition based on eYFP expression and characteristic marker protein expression by immunofluorescence; see quantification in Fig. 2. Scale bars, 50 o n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n u u u u u u u u u u u u u u c l l o n o n n n o n o n n n n o n n n n n n n n n o n o n o n o n o n o n ly ly ly y ly ly ly ly ly ly ly ly ly ly ly ly ly ly ly ly ly ly ly ly ly ly ly y o g e n e e s s s s s s s is is is s s s is s is is is is s i is is is p ro t te in n n o g e n e s s s s s is is is is is is is is is is is s 
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Extended Data Fig. 3 | Validation of TiCRY and DiCRY mouse models. a, Immunohistochemistry confirming HA-tag expression in NSCs of the SVZµm. d, NSCs in TiCRY mice (n = 3 mice) at 4 d.p.i. Green arrow, NSCs; yellow arrows, ENB contamination; white arrow, rare labelled cells outside the SVZ. e, LNBs in olfactory bulb of DiCRY mice (n = 3 mice) at 3 d.p.i.; labelled cells are mostly in the core of the olfactory bulb and express DCX protein. f, ENBs
Statistical parameters
When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main text, or Methods section).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested All studies must disclose on these points even when the disclosure is negative.
Sample size
Since the study was exploratory we chose sample sizes previously used for other transcriptomics studies (Llorens-Bobadilla et al., Cell Stem Cell 2015).
Data exclusions No data was excluded in the course of the study.
Replication
We have biological and technical replicates validating experimental results
Randomization
No randomization was used in the course of this study.
Blinding
For transcriptome and translatome acquirement investigators were not blinded during experiments. For data analysis, investigators were blinded to sample identity.
Reporting for specific materials, systems and methods 
Mycoplasma contamination
Primary cells were not tested for Mycoplasma.
Commonly misidentified lines (See ICLAC register)
Name any commonly misidentified cell lines used in the study and provide a rationale for their use.
Animals and other organisms
Policy information about studies involving animals; ARRIVE guidelines recommended for reporting animal research 
Wild animals
The study did not involve wild animals.
Field-collected samples
The study did not involve samples collected from the field.
Flow Cytometry Plots
Confirm that:
The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
All plots are contour plots with outliers or pseudocolor plots.
A numerical value for number of cells or percentage (with statistics) is provided.
Methodology Sample preparation
Animals were sacrificed by cervical dislocation and their brains immediately placed on ice. The lateral SVZ was microdissected as a whole mount as previously described. SVZs from several mice of 8-16 weeks of age were pooled per replicate. Single cell suspension was obtained using the Neural Tissue Dissociation kit with Trypsin (or Papain when staining for CD31+ and CDd11b+
